Key Findings:  Treatment of mice with cannabidiol markedly attenuated the cisplatin-induced oxidative/nitrosative stress, inflammation, and cell death in the kidney, and it improved renal function. Thus, the results suggest that cannabidiol may represent a promising new protective strategy against cisplatin-induced nephrotoxicity.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  China, United States
Year of Pub:  2009
Cannabinoids Studied:  Cannabidiol (CBD)
Chemotype:  Chemotype III
Ligands Studied:  Anti-inflammatory cytokines, Pro-inflammatory cytokines
Sub-Ratio: 0:1 (THC:CB
Dosage: CBD (2.5 to 10 mg/kg i.p. daily, starting 1.5 h before the cisplatin exposure)
Route of Administration:  Injection